The U.S. operations of Germany-based pharmaceutical giant Bayer has engaged government relation firm Forbes-Tate Partners to communicate health issues on Capitol Hill.
 |
Bayer’s U.S. unit has specifically retained FTP to discuss issues related to 340B, the federal drug pricing program that requires drug manufacturers to provide outpatient drugs at discounted rates to eligible healthcare organizations and various “covered entities” serving the country’s most vulnerable patient populations.
A five-person team handles the Bayer account, including founding partner Jeff Forbes, who formerly served as chief of staff to former Senator Max Baucus (D-MT), staff director to the Senate Finance Committee and deputy political director to President Clinton’s 1996 re-election campaign. He’ll be joined by Libby Greer, former chief of staff to Rep. Allen Boyd (D-FL); Derrick White, former deputy communications director to former U.S. Senator Orrin Hatch (R-UT); Francesca McCrary, former legislative assistant to Rep. Elijah Cummings (D-MD); and Zach Williams, who worked as a top advisor in then-Lt. Governor Lucy Baxley’s 2006 campaign for Alabama Governor.
Forbes-Tate is the bipartisan public affairs consultancy previously known as Cauthen, Forbes & Williams.
Missy Edwards Strategies represents Shein Technology Group, the Los Angeles arm of the embattled Singapore-based “instant fashion” retailer.
Carlsbad, a north San Diego County city of 115K people, is looking for a firm to provide government relations and Sacramento lobbying services.
Gordon Sondland, who was US ambassador to the European Union under Donald Trump, has registered as a representative of Ukraine’s cabinet and ministers.
The Daschle Group is representing Santa Monica-based Stand with Hong Kong Action, an advocacy group that fights to end Chinese repression in Hong Kong.
McKinsey & Co. has reached out to Republican shop Harbinger Strategies to educate policymakers about the activities of the embattled management consultancy.
Have a comment? Send it to 
No comments have been submitted for this story yet.